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Sweethearts	and	bitter	pills	
	
At	the	end	of	a	long,	or	particularly	entangled	love	affair,	there	are	often	conversations	
that	contain	a	certain	sort	of	language,	a	feeling-talk,	full	of	attempts	at	explanations,	
authenticity	and	honesty.	It	is	a	time	for	mapping	and	remapping	neglected	affects,	
putting	aside	desires,	of	trying	to	put	into	words	what	is	not	always	articulated	easily,	
in	a	context	in	which	wrong	words	can	harm.	As	if	at	a	hospital	appointment,	fearful	
but	resolute,	we	speak	to	our	lovers	as	if	we	sense,	but	do	not	know,	the	worst.	‘Please	
doc,’	we	say,	‘just	give	me	the	facts,	don't	sugar	coat	it’.	And	we	listen	hard,	trying	to	
hear	the	diagnosis:	that	there	is	still	a	chance,	or	that	it	is	over,	there	is	no	more	
sweetness	to	be	expected.	The	ground	shifts	beneath	us,	inviting	reinterpretations	and	
a	need	for	remapping	assumptions	and	commitments	that	had	formed	the	backdrops	of	
our	lives,	and	so	we,	or	our	friends,	trying	to	make	sense	of	what	was	once	so	sure,	
might	describe	the	problem	of	acceptance	as	a	‘bitter	pill	to	swallow’.	The	medical	
inflections	of	this	talk	of	truth	and	its	presence	on	the	tongue,	often	described	in	terms	
sweetness	or	its	opposite	point	to	a	metaphorical	entanglement	of	taste,	truth	and	
healing,	and	with	them,	questions	of	trust	and	honesty.	These	questions	not	only	reside	
in	hospitals	and	clinics,	but	throughout	our	relationships	with	those	for	whom	we	care.	
	
Truth,	trust	and	healing	
Truth	is	a	perennial	problem	for	the	physician,2	in	a	number	of	ways	it	complicates	
diagnosis;	the	need	to	read	the	signs	of	an	inscrutable,	still	breathing	body	as	indices	of	
disorder	with	known	treatments.	These	signs	not	only	tell	its	present	state,	but	forecast	
                                            
1	With	thanks	to	Prof	dr.	Michael	Punt	for	his	careful	yet	repeated	readings	and	thoughtful	comments	on	the	
draft,	to	Ellie	Doney	for	many	pointers	and	starting	conversations,	and	comments	on	the	draft.	Thanks	to	
Hannah	O’Sullivan	for	telling	me	about	the	use	of	glucose	in	neonatal	care.	
2	Daniel	K.	Sokol,	‘How	the	doctor’s	nose	has	shortened	over	time;	a	historical	overview	of	the	truth-telling	
debate	in	the	doctor–patient	relationship’.	Journal	of	the	Royal	Society	of	Medicine,	Vol.	99.	(2006).	632–636.	
Stephen	Tyreman.	‘Trust	and	truth:	uncertainty	in	health	care	practice’.	Journal	of	Evaluation	in	Clinical	
Practice,	21(3),	(2015).	470–478.	http://doi.org/10.1111/jep.12332		
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future	developments,	they	help	us	discover	the	natural	history	of	an	illness	and	reveal	a	
prognosis.	More	than	this,	as	patients,	we	may	be	ambivalent	about	hearing	what	fate	has	
in	store	for	us.	As	doctors,	we	must	sometimes	present	certainties	with	equivocation,	and	
doubts	as	certainties.3	The	very	idea	that	there	is	a	truth	to	be	told	about	either	one’s	
feelings	or	one’s	future	health	relies	on	the	idea	that	such	a	truth	exists,	that	it	is	possible	to	
know,	and	even	the	assumption	that	the	future	is	determined	by	the	present.	We	can	
perhaps	more	easily	ascertain	the	physical	world	of	medium-sized-objects,	but	the	complex	
systems	of	the	body,	especially	for	those	working	within	the	disciplines	of	medical	or	
psychological	science,	may	more	often	be	better	described	in	terms	of	probabilities.	The	
variety	of	maladies	and	disorders	we	might	suffer;	just	like	our	experiences	of	love,	are	
given	form	and	nuance	by	the	historical	periods	and	the	linguistic,	cultural	and	technical	
apparatus	that	we	have	to	hand	to	negotiate	them.4		
	
Metaphors	where	giving	and	taking	truth	as	if	it	were	medicine	point	to	another	
problem:	how–	if,	even–	to	break	the	news.	How	to	make	it	palatable.	The	central	tenet	of	
the	Hippocratic	Oath,	‘do	no	harm’	is	quiet	on	the	nuances	of	how	exactly	we	might	
navigate	the	waters	between	compassion	and	‘tough	love’.	Both	Hippocrates	and	Plato	
considered	deception	as	valid	tools	for	the	physician:	‘words	were	seen	as	having	the	
power	to	increase	or	alleviate	the	suffering	of	patients’.5	The	question	of	whether	or	not	to	
lie	to	patients	was	most	often	debated	with	reference	to	lying	being	a	sin	and	therefore	
problematic,	if	possible	it	was	most	often	recommended	that	the	‘bad	medicine’	of	a	
‘gloomy	prognostication’	was	withheld	from	patients.6	As	Daniel	Sokol	suggests	‘In	this	
context	of	therapeutic	paucity,	hope-instilling	deception	may	have	been	an	important	
weapon	in	a	doctor's	remedial	arsenal’.	Starting	in	the	1950s,	attitudes	changed	towards	
practices	of	misleading,	or	simply	not	informing	patients	of	a	negative	prognosis.	Sokol	
suggests	that	this	shift	was	likely	associated	with	the	availability	of	pharmaceutical	drugs	
as	viable	treatment	options.	Tenets	of	patient	autonomy,	enabled	by	informed	choice	
through	physician	openness	and	transparency	have	become	central	to	the	codes	of	20th	
century	medicine7.	Despite	this,	the	question	of	exactly	how	to	‘break	bad	news’	is	far	from	
resolved.8	There	are	plenty	of	reasons	to	bend	the	truth,	from	self-interested	deceit,	to	
more	benevolent	goals	that	might	still	invite	us	to	treat	information,	or	lack	of	it,	as	a	kind	
                                            
3	This	is	a	discussion	that	seems	much	less	muddy	in	the	theoretical	ethical	argument	than	in	practice.	
4	Caroline	Duffin’s	Lovers	and	Livers,	tells	the	story	of	love’s	time	as	a	physiologically	manifest	disease.	
Duffin,	J.,	Lovers	and	Livers;	Disease	Concepts	in	History,	Toronto,	Buffalo,	London:	University	of	Toronto	Press.	
(2005).	
5	Marco	Annoni	and	Franklin	G.	Miller,	Placebo	Effects	and	the	Ethics	of	Therapeutic	Communication,	Kennedy	
Institute	of	Ethics	Journal	Vol.	26,	No.	1,	79–103.	(2006),	80.	
6	Sokol,	‘How	the	doctor’s	nose	has	shortened	over	time’.	(633)	Sokol	charts	a	dramatic	shift	in	US	
physician's	attitudes	to	informing	their	patients	of	a	cancer	diagnosis,	where	in	1953	over	half	surveyed	said	
that	they	would	never	reveal	such	a	diagnosis,	because	of	the	negative	emotional	effects.	(634)	He	points	out	
more	recent	research	on	what	surgeons	reveal	to	patients	regarding	malignancies	suggest	that	there	remains	
a	discrepancy	between	the	medical	guidelines	that	medics	purport	to	be	following	and	how	this	is	manifests	
in	practice.	(635)	
7	For	a	thorough	analysis	of	lying,	deception,	misleading	etc.	in	the	medical	context	see:	Jennifer	Jackson,	
Truth,	Trust	and	Medicine,	London	and	New	York:	Routledge,	(2001).	
8	Lesley	Fallowfield	and	Valerie	Jenkins.	“Communicating	Sad,	Bad,	and	Difficult	News	in	Medicine.”	The	
Lancet	363	(9405):	312–19.	doi:10.1016/S0140-6736(03)15392-5.	(2004).	
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of	medicine.	Are	the	facts	always	helpful	in	recovery?9	What	and	how	do	we	tell	people	if	
we	don’t	want	them	to	lose	hope?10	Would	a	bitter	pill	make	a	better	medicine?	
	
Honesty	and	healing:	A	spoonful	of	sugar	
Sugar	in	healing	has	a	long	lineage.	The	archetypal	‘sugar	pill’	is	the	placebo	tablet,	
named	for	the	Greek,	‘I	shall	please’	from	‘placare’	to	placate.	The	placebo’s	sugary	nature	is	
as	much	symbolic	as	factual,	as	often	placebos	are	made	from	other	ingredients–	whatever	
met	the	expectations	of	the	patient,	or	the	needs	of	the	trial	best.		Olive	oil	capsules,	lactose	
powder,	bread	pills,	injections	of	saline,	and	coloured	water,	syrups11	are	all	variants	on	the	
sugar	placebo.	As	well	as	being	given	by	medics	more	often	than	we	might	usually	expect,12	
placebos	are	used	as	dummy	treatments	in	medical	trials	to	isolate	the	effects	of	being	
treated	from	the	specific	treatment	being	tested.		
	
Untangling	the	mechanisms	by	which	interventions	other	than	medical	treatments	lead	
to	improvement	in	patients	isn’t	an	especially	simple	matter.13	What	experiments	
comparing	different	placebo	treatments	show	is	that	one	factor	in	influencing	the	
effectiveness	of	some	medical	treatments	is	the	way	in	which	the	treatment	is	presented.	In	
the	case	of	medicines,	factors	such	as	colour	and	shape	of	tablets,	or	the	way	in	which	the	
medicine	is	administered–	for	example	tablet	vs	injection,	all	influence	treatment	
outcomes.14	Placebo	healing	now	has	a	well-established	place	in	medical	literature,	and	
recognition	of	the	potential	for	deception	to	heal	has	motivated	researchers	concerned	
                                            
9	Daniel	Moerman,	(2002)	Meaning,	Medicine	and	the	‘Placebo	Effect,’	Cambridge:	Cambridge	University	Press.	
10	Bad	news	might	be	understood	to	directly	harm	patients	through	negative	placebo	or	‘nocebo’	effects	see;	
Rebecca	Wells,	and	Ted	Kaptchuk,	To	Tell	the	Truth,	the	Whole	Truth,	May	Do	Patients	Harm:	The	Problem	of	
the	Nocebo	Effect	for	Informed	Consent.	The	American	Journal	of	Bioethics,	12(3),	22–29.	(2012).	
http://doi.org/10.1080/15265161.2011.652798	
For	a	recent	review	of	the	discussion	around	training	in	giving	bad	news	see:	Fallowfield,	L.,	&	Jenkins,	V.	
Communicating	sad,	bad,	and	difficult	news	in	medicine.	The	Lancet,	363(9405).	(2004)	312–319.	
http://doi.org/10.1016/S0140-6736(03)15392-5	
11	More	recently	materials	that	are	thought	to	be	entirely	inert	when	they	are	in	the	human	digestive	system	
have	been	used	to	make	dummy	pills,	such	as	micro-crystalline	cellulose,	this	material	is	also	used	as	a	filler	in	
tablet	pressing.	A	common	use	of	sugar	pills	is	in	birth	control	tablets,	where	sucrose	tablets	are	added	to	
packs	on	specific	days	in	order	to	provide	a	5-day	period	of	bleeding	that	simulates	menstruation.	
For	an	overview	of	the	available	in	Beatrice	Golomb,	‘What’s	in	Placebos:	Who	Knows?	Analysis	of	
Randomized,	Controlled	Trials’,	Annals	of	Internal	Medicine.	(2010),	534.		
12	A	number	of	studies	have	documented	GPs	offering	placebo	treatments,	for	an	overview	and	analysis	of	the	
way	in	which	medical	professionals	and	their	patients	see:	Doug	Hardman,	et	al.	“From	Substance	to	Process:	
a	Meta-Ethnographic	Review	of	How	Healthcare	Professionals	and	Patients	Understand	Placebos	and	Their	
Effects	in	Primary	Care.”	Health:	an	Interdisciplinary	Journal	for	the	Social	Study	of	Health,	Illness	and	Medicine	
19	(September):	136345931880016–26.	doi:10.1177/1363459318800169.	(2018)	Often	instead	of	using	
outright	deception,	drugs	such	as	antidepressants	are	given	at	below	active	dose	or	to	treat	illness	for	which	
they	would	not	have	any	known	effect,	such	as	the	provision	of	antibiotics	for	patients	with	a	cold.		
13	A	recent	useful	analysis	is	offered	by	Jeremy	Howick.	The	relativity	of	‘placebos’:	defending	a	modified	
version	of	Grünbaum’s	definition.	Synthese,	194(4),	(2016)	1363–1396.	http://doi.org/10.1007/s11229-015-
1001-0	
14	Moerman,	Meaning,	Medicine	and	the	Placebo	Effect.		
For	a	discussion	of	some	of	the	epistemological	implications	of	thinking	about	placebo	effects	in	art	and	
particularly	design	practice	see–	Hannah	Drayson,	‘Design	(ing)	and	the	Placebo	Effect-A	Productive	Idea’.	
Design	Issues,	MIT	Press.	(2018).	http://doi.org/10.1162/desi_a_00494	
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with	harnessing	these	effects	and	the	ethical	implications	of	the	‘dishonest’	pill.15	In	the	
case	of	the	placebo,	whether	through	deception	or	design,	what	is	central	is	that	the	
placebo	treatment	creates	a	perceived	disjuncture	between	form	and	material	in	which	the	
content,	or	lack	of	it,	is	hidden	from	us.	Sugary	pills	can	play	at	least	two	roles	in	medicine;	
either	as	coating,	to	help	‘real’	medicine	to	go	down,	or	to	substitute	it	entirely	offering	a	
pharmacologically	inert	object,	that	stands	in	symbolically	for	a–	perhaps	non-existent–	
treatment.			
	
Sweetness	as	medicine.	
	 Through	the	efficiency	of	its	production	and	calories	per	acre,	sugar	offered	a	highly	
efficient	crop	in	historical	periods	of	rapid	population	growth.	Sugar	has	funded	empires,	
and	fuelled	armies	and	workers.16	A	ubiquitous	component	of	the	western	diet,	its	
overconsumption	is	now	considered	a	social	and	health	problem.	Yet	it	wasn’t	always	so	
maligned.	In	addition	to	the	function	of	stand-ins	or	flavour	masks,17	cane	sugar,	up	until	
the	late	middle-ages	was	a	spice,	an	exotic	additive.18	It	was	also	considered	an	important	
medical	substance,	a	stimulant	and	used	to	bind	together	other	materials	such	as	spices	or	
as	part	of	a	variety	of	bitters	and	tonics. 	Honey,	made	by	a	species	of	bee	originally	native	
to	the	Mediterranean,	has	even	more	ancient	meanings	as	a	medical,	and	magical	substance,	
particularly	prized	for	its	exceptional	quality	as	a	preservative	which	meant	that	it	was	
used	in	Egyptian	mummification	practices.		
	
                                            
15	There	is	now	also	work	going	on	with	‘meta-placebo’	or	‘open	label’	placebo,	in	which	the	false	medicine	is	
given	openly,	accompanied	by	information	about	the	beneficial	effects	of	placebo	and	strangely	this	too	has	
been	found	effective.		
Oskar	van	Deventer.	Meta-placebo:	Do	doctors	have	to	lie	about	giving	a	fake	treatment?	Medical	Hypotheses,	
71(3),	(2008).	335–339.	http://doi.org/10.1016/j.mehy.2008.03.040	
For	an	example	trial;	Ted	Kaptchuk,	et	al.	Placebos	without	Deception:	A	Randomized	Controlled	Trial	in	
Irritable	Bowel	Syndrome.	(2010).	PLoS	ONE,	5(12),	e15591–7.	
http://doi.org/10.1371/journal.pone.0015591	
16	Mintz,	Sweetness	and	Power.	
17	Even	in	medieval	pharmacy,	pills,	as	balls	or	tables	of	material	moulded	or	cut	were	coated	with	other	
materials,	including	plant	substances	and	even	precious	metals	in	medieval	times	to	mask	their	flavour.	In	the	
1800s	sugar	was	added	to	the	list	of	substances	used	for	this	purpose.	It	was	in	1843	that	an	English	chemist	
devised	a	process	for	pressing	tablets	from	dry	materials.	In	the	case	of	many	contemporary	drugs,	the	
extremely	unpleasant	bitterness	of	their	flavour	has	led	to	the	invention	of	many	different	processes	of	
‘flavour	masking’	where	compounds	are	coated	in	waxes	or	polymers	that	will	not	dissolve	in	saliva,	only	
releasing	the	drug	once	it		has	reached	the	stomach.	While	bitter	compounds	might	be	sealed	in	tablet	form,	
given	the	difficulty	of	getting	babies,	children	and	the	elderly	to	take	tablets,	the	question	of	how	to	mask	
flavours	in	liquids	is	still	an	issue.		
George	Griffenhagen	and	Glenn	Sonnedecker	Apothecary:	A	History	of	Sugar	Coated	Pills	and	Tablets.	Journal	
of	the	American	Pharmaceutical	Association	(Practical	Pharmacy	ed.)Volume	18,	Issue	9,	September	1957,	
553-555.	
Julie	Mennella,	and	Gary	Beauchamp.	(2008).	Optimizing	oral	medications	for	children.	Clinical	Therapeutics,	
30	(11),	2120–2132.	http://doi.org/10.1016/j.clinthera.2008.11.018	
Nicole	Gaudette	and	Gary	Pickering	(2013).	Modifying	Bitterness	in	Functional	Food	Systems.	Critical	Reviews	
in	Food	Science	and	Nutrition,	53(5),	464–481.	http://doi.org/10.1080/10408398.2010.542511	
18		‘[…]	an	exotic	condiment,	properly	classifiable	with	pepper,	cinnamon,	nutmeg,	cloves	and	mace	a	flavour	
of	the	orient	which	could	transmute	food	and	elevate	it	out	of	the	ordinary.’	Felipe	Fernández-Armesto,	Food,	
A	History.	London	:	Macmillan.	(2001)	205-6.	
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	 It	is	no	accident	that	the	virtues	of	sweetness	persist	today,	partly	as	placebo,	through	
considered	branding	in	which	the	presentation	of	medicines	have	become	hooked	up	with	
tastes	and	expectations.19	Some	of	the	oldest	print	advertising	was	aimed	at	the	marketing	
of	what	were	called	‘patent	medicines’,	nostrums,	often	syrups,	which	contained	cocktails	
of	ingredients	and	were	intended	as	cure	alls.	Advertised	in	periodicals,	they	were	also	sold	
over	the	counter	but	most	commonly	through	the	public	performance	of	a	‘medicine	show’	
which	used	a	variety	of	entertainments	to	draw	in	an	audience	and	then	sell	the	‘snake	oil’.	
The	claims	made	for	these	cocktails	might	seem	quaint,	but	if	we	look	to	the	present	day,	
the	size	of	the	pharmaceutical	industry	and	the	way	in	which	marketing	shapes	
contemporary	imaginations	and	myths,	presents	a	somewhat	sinister	relationship.20	In	
conter	David	Healy’s	Pharmageddon	explores	the	way	in	which	drug	marketing	practices	
seek	to	exploit	patents	on	specific	medicines.	They	do	this	by	identifying	the	concerns	of	
doctors	and	then	specifically	designing	campaigns	to	raise	awareness	of	conditions	and	
syndromes	rather	than	treatments;	‘When	a	pharmaceutical	company	gets	a	drug	on	the	
market	for	lowering	cholesterol,	for	osteoporosis,	or	for	erectile	dysfunction,	this	now	
marks	the	point	at	which	the	company	begins	to	sell	the	condition,	the	point	at	which	they	
can	gear	up	to	reengineer	the	medical	marketplace	to	suit	their	product.’21	For	example	
starting	in	1995,	manic-depression,	a	severe	condition	usually	requiring	hospitalisation,	
has	been	rebranded	as	the	apparently	far	more	common	bipolar	disorder.	To	complement	
this	newer	understanding	of	bipolar	as	epitomised	by	unhelpfully	fluctuating	moods,	the	
new	category	of	‘mood	stabilisers’	was	invented,	as	a	way	to	rebrand	and	identify	larger	
and	more	specific	markets	for	existing	drugs	such	Depakote.22		While	we	can	consider	
these	industries	with	the	suspicion	they	deserve,	we	can	also	take	note	of	what	they	tell	us	
about	healing	as	a	practice	of	communication,	context,	and	the	management	of	expectations	
(and	how	these	have	been	hijacked	to	become	a	norm).	While	medicine	is	often	now	
recognised	as	a	series	of	consumable	products	and	treatments,	epitomised	by	the	pill	as	
object,	the	imaginaries	and	concepts	that	the	pharmaceutical	industry	has	developed	
around	them	to	make	sense	of	the	products	they	offer	increasingly	shape	contemporary	
subjectivities23	and	bodily	awareness.		
	
A	Bitter	Pill	
	 In	his	essay	on	the	psychosociology	of	food	Roland	Barthes	looks	for	a	way	in	to	move	
beyond	our	understanding	of	sugar	as	merchandise	or	nutritional	substance,	but	as	‘a	
                                            
19	A	particularly	old	brand	is	the	luxury	product	Lyle’s	Golden	Syrup,	developed	by	the	Lyle	family	in	1885,	
and	originally	based	on	a	by-product	of	the	sugar	refining	process.	Health,	refinement	and	purity	were	key	
problems	for	the	consuming	public	as	food	production	became	industrialised.	Through	its	virtuous	markets	
Golden	Syrup,	a	synthetic	by-product	was	able	to	mimic	honey,	substituting	it	as	a	material,	thick,	golden	and	
viscous,	as	well	as	in	the	packaging	which	referenced	a	long	history	of	bees	as	sacred	creatures.	Until	the	
1950s	it	was	held	by	some	to	be	a	superior	and,	because	of	its	homogenous	quality,	pure	substance.		
Philippe	Chalmin,	The	Making	of	a	Sugar	Giant:	Tate	and	Lyle,	1859-1989.	(1990).	Chur:	Harwood	Academic	
Publishers.	(101-2)		
20	Robert	Bennett’s	Pill	gives	a	good	overview	of	the	recent	‘rapid	and	pervasive	explosion–not	just	of	
psychiatric	drugs	themselves,	but	of	an	entire	psychopharmacological	paradigm’.	Robert	Bennett,	Pill.	New	
York:	Bloomsbury	Academic.	(2019)	(27)	
21	David	Healey.	Pharmageddon.	Berkley	and	Los	Angeles:	University	of	California	Press.	(2012)	
22	Healey,	Pharmageddon	:	35.	
23	Robert	Bennett,	Pill	:	1-30.	
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concrete	item	that	is	eaten’.	24	Rather	that	this	being	a	simple	matter,	he	describes	different	
foods	as	being		‘institutions’	each	of	which	‘imply	a	set	of	images,	dreams,	tastes,	choices	
and	values’.25	Particularly	in	the	case	of	consumer	goods	which	are	manufactured,	
standardised	and	‘ideal	in	nature’,	the	symbolic	function	of	a	food	comes	to	overshadow	the	
‘mass	of	indifferent	materials’	from	which	it	is	produced.26	As	Barthes	describes	it,	while	
food	gives	strength	to	the	organism,	that	strength	is	immediately	sublimated	to	particular	
situations,	its	meaning	is	shifted	in	sometimes	paradoxical	ways.	He	gives	the	example	of	
coffee,	no	longer	associated	with	the	stimulation	that	purportedly	made	possible	the	
French	Revolution,	coffee	is	now	synonymous	with	taking	breaks,	socialising	and	the	
relaxation	from	work.	In	contemporary	French	society	then	‘coffee	is	not	so	much	a	
substance,	as	a	circumstance	[…]	organically	integrated	into	its	specific	type	of	
civilisation’.27	These	‘deformations	or	reconstructions	are	[…]	elements	of	a	veritable	
collective	imagination,	showing	the	outlines	of	a	certain	mental	framework’	and	a	‘body	of	
images,	a	protocol	of	usages,	situations	and	behaviour’.28		
	
	 This	body,	for	Barthes,	presents	a	‘spirit’	of	food	that	brings	together	flavour	and	
substance.	He	points	here	towards	advertising	media	and	the	dimension	of	the	
phenomenological,	suggesting	that	our	understanding	might	benefit	from	a	Bachelardian	
‘poetic’	analysis29.	He	gives	the	example	of	the	word	‘crisp’	which	combines	a	number	of	
somewhat	contradictory	images	and	sensations,	showing	that	‘the	unit	of	food	can	
overthrow	logical	categories’	and	‘goes	beyond	the	purely	physical	nature	of	the	product’;	
	
Crisp	designates	everything	that	crunches,	crackles,	grates,	sparkles,	from	potato	chips	
to	certain	brands	of	beer;	crisp	-	crisp	may	be	applied	to	a	product	just	because	it	is	ice	
cold,	to	another	because	it	is	sour,	to	a	third	because	it	is	brittle.	[…]	crispness	in	a	food	
designates	an	almost	magical	quality,	a	certain	briskness	and	sharpness,	as	opposed	to	
the	soft,	soothing	character	of	sweet	foods.30	
	
‘Night	Nurse,	Oh	the	Pain	is	Getting	Worse’.31	
                                            
24	Roland	Barthes,	‘Toward	a	psychosociology	of	contemporary	food	consumption’.	Food	and	culture:	a	reader.	
Carole	Counihan	and	Penny	Van	Esterik	(eds)	(2008)	New	York:	Routledge:	(28)			
Barthes	begins	his	essay	by	pointing	out	the	disparity	between	the	consumption	of	sugar	in	French	and	
American	culture.	Commenting	on	this,	Mintz	suggests	that	there	are	variations	in	the	palates	of	the	two	
cultures	which	means	that	French	wine	and	coffee	culture	may	have	lowered	the	country’s	overall	tendency	
toward	the	consumption	of	sweet	substances.	While	to	an	extent	there	is	a	training	of	the	palate	that	allows	us	
to	appreciate	coffee,	tobaccos	and	wine	–	along	with	the	disposable	income	necessary	to	secure	these	
commodities	it	is	also	the	case	that	older	mouths	contain	less	bitter	sensitive	taste	buds.	It	is	in	fact	the	
deadening	of	our	senses	that	allows	us	to	be	less	distressed	by	the	distaste	of	unpleasant	flavours	and,	quite	
possibly	the	shifting	meaning	of	sweetness	as	we	mature.	
Sidney	W.	Mintz,	Sweetness	and	Power:	The	place	of	sugar	in	modern	history.	NY:	Viking	(1985)	:	189.		
25	Barthes,	Toward	a	psychosociology,	29.	
26	Barthes,	Toward	a	psychosociology,	31.	
27	Barthes,	Toward	a	psychosociology,	34.	
28	Barthes,	Toward	a	psychosociology,	29.	
29 Barthes, Toward	a	psychosociology,	31. 
30	Barthes,	Toward	a	psychosociology,	31.	
31	Jeremy	Isaacs,	Night	Nurse.	(1982).	Island	Records.	
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Perhaps	it	is	that	soft,	soothing	character	that	makes	sweetness	so	useful	in	medicine,	
and	characterises	its	own	‘spirit’	or	‘unit	of	food’.	In	a	paper	about	the	placebo	effects	of	
cough	medicines,	Ronald	Eccles	discusses	the	large	number	of	foul	tasting	cures	intended	
for	the	treatment	of	a	cough	in	the	Merk’s	Materia	Medica,	suggesting	the	taste	of	the	
medicine	is	as	important	as	its	effect.	While	traditionally	the	inclusion	of	sweet	agents	
would	have	been	intended	to	cover	up	these	unpleasant	tastes,	recent	research	suggests	
that	it	is	the	sweet	taste	of	the	syrup	itself	that	has	a	suppressant	effect	on	a	cough.32	
	
	 Maybe	it	is	because	of	the	way	sugar	can	be	used	to	mask	taste,	syrup-based	medicines	
are	a	ubiquitous	figure	in	pediatric	medicine.	In	the	United	Kingdom,	the	National	Health	
Service	currently	provides	a	set	of	vaccinations	for	new	babies	when	they	reach	6	weeks	
old.	To	prevent	fever	brought	on	by	the	meningitis	B	vaccines,	and	to	reduce	pain	at	the	site	
of	injection,	babies’	carers	are	advised	to	give	them	2	doses	of	liquid	paracetamol.	
Recognisable	for	its	chalky,	bitter	taste,	paracetamol	is	the	most	common	analgesic	
medicine	in	use	in	the	UK.	In	1959	it	began	to	be	sold	by	Calmic	Ltd.	suspended	in	a	sugary	
solution	that	masked	the	bitter	flavour	and	meant	that	it	could	be	administered	to	children	
under	the	name	‘Calpol’.	The	experience	of	being	fed	this	glistening	sucrose	on	a	small	
plastic	spoon,	the	sides	of	which	almost	cutting	into	the	upper	lip	is,	for	people	who	grew	
up	in	the	United	Kingdom	an	easily	invoked	and	ubiquitous	childhood	memory.	As	Jenny	
Kleeman	suggests	in	a	recent	article	for	the	Guardian,	the	ubiquity	of	Calpol	in	
contemporary	parenting,	and	the	accompanying	marketing	campaigns	that	have	connected	
the	drug	with	calm,	sleeping	babies	has	led	to	a	situation	in	which	parents	are	
‘psychologically	dependent’	on	Calpol	as	a	placebo.	As	she	suggests,	it	is	not	the	
paracetamol,	but	the	lowering	of	parental	anxiety	that	may	be	calming	fractious	children.33		
	
	 The	attempt	to	comfort	pain	with	sweetness	also	manifests	in	the	use	of	‘sucrose	
administration’	as	‘non-pharmacological	analgesia’	for	new-born	babies	when	they	are	
subjected	to	painful	tests	after	birth.34	While	using	sugar	for	pain	relief	is	as	old	as	the	hills,	
it	seems	a	practice	tinged	with	guilt,	due	to	the	deception	involved.	Masking	bitter	flavours	
                                            
32	Ronald	Eccles,	Mechanisms	of	the	placebo	effect	of	sweet	cough	syrups.	Respiratory	Physiology	&	
Neurobiology,	152(3),	(2006).	340–348.	http://doi.org/10.1016/j.resp.2005.10.004		
While	Schroeder	and	Fahey	concluded	that	there	was	no	reason	to	recommend	cough	syrups	because	their	
effects	were	no	better	than	placebo,	Eccles	points	out	that	this	does	not	mean	that	they	are	not	a	useful	
placebo	treatments,	given	that	they	are	more	effective	than	no	treatment.	As	Cohen	comments;	‘Parents	and	
physicians	want	symptomatic	relief	of	cough	associated	with	upper	respiratory	tract	infections.	If	a	placebo	is	
low	cost,	has	no	or	minimal	adverse	effects,	and	it	can	reduce	unnecessary	antibiotic	treatment,	it	appears	to	
be	a	preferable	treatment	option.’(1321)		
Herman	Cohen,	Demonstration	of	placebo	effect	for	nonspecific	cough	medicine.	The	Journal	of	Pediatrics,	
166(5),	1320–1323.	(2015).	http://doi.org/10.1016/j.jpeds.2015.02.060	
Knut	Schroeder	and	Tom	Fahey,	‘Systematic	review	of	randomised	controlled	trials	of	over	the	counter	cough	
medicines	for	acute	cough	in	adults’.	BMJ	(Clinical	Research	Ed.),	324(7333),	(2002).	329–331.	
http://doi.org/10.1136/bmj.324.7333.329	
Paul	M	Wise,	Paul	Breslin,	Pamela	Dalton.	‘Sweet	taste	and	menthol	increase	cough	reflex	thresholds.’	
Pulmonary	Pharmacology	&	Therapeutics,	25	(2012).		
33	Jenny	Kleeman,	‘Why	parents	are	addicted	to	Calpol’.	The	Guardian.	(2019).	Retrieved	June	6,	2019,	from	
http://www.theguardian.com/lifeandstyle/2019/jun/04/why-parents-are-addicted-to-calpol	
34	Chris	Henderson	and	Sue	Macdonald,	(eds)	Mayes	Midwifery:	A	textbook	for	midwives.	Edinburgh:	Baillire	
Tindall.	(2004)	p.261.	
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is	what	we	do	in	order	to	get	children	to	eat	things	they	would	naturally	refuse.	A	potential	
irony	is	that	this	method	of	pain	reduction	may	only	appear	effective	in	infants	because	
giving	them	sugar	reduces	their	grimace	response,	which	is	one	of	the	few	measures	of	pain	
available.35		
	
The	end	of	the	affair	
	
The	metaphorical	potency	of	sweetness	as	a	mediator	of	pain	as	opposed	to	the	
bitterness	which	we	might	‘stomach’,	points	toward	the	nature	of	the	‘spirit’	of	this	
functional	food.	When	given	to	a	lover,	sugar	mimics	the	giddiness	and	intoxication	of	a	
new,	or	reignited	love	affair,	but	perhaps	also	serves	as	a	Trojan	horse.	Is	a	box	of	
chocolates	the	indulgence	in	advance	of	pain,	the	glucose	drops	that	are	given	before	the	
heel	prick?	As	a	bribe,	it	is	an	anxious	and	paternalistic	one,	a	pact	made	with	an	unruly	
child	that	doesn’t	know	what	is	good	for	it,	to	get	things	down	the	virtuous	gullet,	broccoli	
precedes	chocolate	mousse.	Perhaps	a	sugared	pill	is	better,	because	in	the	end,	it	shows	us	
that	someone	cares	enough	to	lie.	
	
The	placebo	functions	of	sweet	tastes	show	how	sugar	syrups	have	a	special	place	
within	material	and	medical	culture,	a	place	that	has	multiple	functions.	In	their	
entanglements	with	care,	and	those	we	care	for,	sweetness	offers	a	mask,	a	distraction	and	
perhaps	an	apology	for	what	we	cannot	fix.	While	perhaps	there	is	a	sense	that	what	is	good	
for	us	should	hurt,	this	mobility	of	meaning	is	somehow	mapped	onto	the	same	ambiguities	
of	love,	care,	and	all	the	tough	responsibilities	that	they	carry.	Perhaps	only	this	can	at	the	
same	time	explain	sugar’s	effectiveness	in	scientifically	suspect	medicines	and	why	one	of	
the	best	cures	for	a	broken	heart	is	still	a	bar	of	chocolate.		
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